GSK to introduce Infanrix DTPa vaccine in Korea
Published: 2003-06-19 06:56:00
Updated: 2003-06-19 06:56:00
GlaxoSmithKline Korea said that Infanrix DTPa vaccine, which has been widely used all over the world, will be launched in domestic market from June 23 after fulfilling necessary procedures such as state-run tests and packaging work.
A GSK official noted that Infanrix was officially registered ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
